[EN] COT MODULATORS AND METHODS OF USE THEREOF<br/>[FR] MODULATEURS DE COT ET LEURS PROCÉDÉS D'UTILISATION
申请人:GILEAD SCIENCES INC
公开号:WO2020252151A1
公开(公告)日:2020-12-17
The present disclosure relates generally to modulators of Cot (cancer Osaka thyroid) of generic Formula (I) and methods of use and manufacture thereof.
4,6-DIAMINO-QUINOLINE-3-CARBONITRILE DERIVATIVES AS CANCER OSAKA THYROID (COT) MODULATORS FOR TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS
申请人:Gilead Sciences, Inc.
公开号:EP3896064A1
公开(公告)日:2021-10-20
The present disclosure relates to 4,6-diamino-quinoline-3-carbonitrile derivatives for use as modulators of COT (Cancer Osaka Thyroid) in methods of treating Crohn's disease and ulcerative colitis.